---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-041436"
form_type: "8-K"
ticker: "OCEA"
cik: "0001869974"
company_name: "Ocean Biomedical, Inc."
filed_at: "2024-10-17T23:59:59+00:00"
generated_at: "2026-05-30T13:26:58.813998+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Ocean Biomedical ratifies revised Virion agreement to acquire up to 22% stake for $9M

## Summary
- Board ratified revised agreement dated Nov 2023, received Sep 26, 2024; Ocean to own 22% of Virion fully diluted.
- $9M aggregate capital contribution paid via cash and/or equity; $960k already credited.
- Virion will sell 500,000 OCEA shares held; proceeds count toward $9M.
- If proceeds below $9M by Apr 1, 2025, Ocean may pay difference in cash or stock.
- Max common interests: 10,933,155; initial 1,166,203 already issued (2.34% as of Aug 21, 2024).

## SEC filing metadata
- accession: 0001493152-24-041436
- form_type: 8-K
- ticker: OCEA
- cik: 0001869974
- company_name: Ocean Biomedical, Inc.
- filed_at: 2024-10-17T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1869974/000149315224041436/0001493152-24-041436-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1869974/000149315224041436/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-041436
- JSON: https://secwatch.observer/filing/0001493152-24-041436.json
- Plain text: https://secwatch.observer/filing/0001493152-24-041436.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.